Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)

NCT02823951 is registered in ClinicalTrials.gov with IMS HEALTH GmbH & Co. OHG as lead sponsor.

NCT NCT02823951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Lead sponsor
IMS HEALTH GmbH & Co. OHG
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
February 28, 2018
Enrollment
479 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis